Intervention not reported
Adverse events that result in the discontinuation of treatment · adults and children with confirmed clinical and parasitological P vivax malaria
It is very uncertain whether the intervention changes adverse events that result in the discontinuation of treatment (very low certainty).
1 finding from 1 review
Safety outcomes: drug discontinuation · adults with HIV and progressive disseminated histoplasmosis
It is very uncertain whether induction: liposomal amphotericin changes safety outcomes: drug discontinuation compared with amphotericin deoxycholate (very low certainty).
1 finding from 1 review
Intervention not reported
Treatment discontinuation due to adverse event (safety population) · women with metastatic triple‐negative breast cancer (mTNBC)
The intervention probably leads to lower treatment discontinuation due to adverse event (safety population) (moderate certainty).
1 finding from 1 review
Intervention not reported
All‐cause discontinuation · vascular dementia, mild‐to‐moderate severity
1 finding from 1 review
Intervention not reported
All‐cause discontinuation · Alzheimer's disease (AD), moderate‐to‐severe
1 finding from 1 review
Rate of discontinuation due to menstrual disturbances · Women of reproductive age seeking to avoid pregnancy
Intensive counseling may leads to lower rate of discontinuation due to menstrual disturbances compared with usual family planning care (low certainty).
1 finding from 1 review
Rate of discontinuation due to all other adverse events · Women of reproductive age seeking to avoid pregnancy
Intensive counseling showed no clear difference in rate of discontinuation due to all other adverse events compared with usual family planning care (low certainty).
1 finding from 1 review
Discontinuation of medication due to adverse events · Women of reproductive age seeking to avoid pregnancy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Discontinuation of medication due to adverse events · adults with acute respiratory distress syndrome
It is very uncertain whether surfactants changes adverse events Defined as leading to discontinuation of study… compared with control (very low certainty).
1 finding from 1 review
Discontinuation of medication due to adverse events · adults with acute respiratory distress syndrome
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Discontinuation of medication due to adverse events · adults with acute respiratory distress syndrome
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Discontinuation of medication due to adverse events · adults with acute respiratory distress syndrome
1 finding from 1 review
Adverse events Defined as leading to discontinuation of study medication; or for studies with standard care control, defined by study authors as "serious adverse events" · adults with acute respiratory distress syndrome
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Withdrawals due to adverse events · adults with a history of SAD who do not fulfil criteria for major depressive disorder
Bupropion XL showed no clear difference in discontinuation due to adverse events compared with placebo (low certainty).
1 finding from 1 review
Overall discontinuation ( · All participants were known SAD patients who had been successfully treated with conventional light therapy in previous winters
It is very uncertain whether bright white light therapy changes overall discontinuation ( compared with infrared light therapy (very low certainty).
1 finding from 1 review
Overall discontinuation ( · All participants were known SAD patients who had been successfully treated with conventional light therapy in previous winters
It is very uncertain whether bright white light therapy changes overall discontinuation ( compared with no light therapy (very low certainty).
1 finding from 1 review
Overall discontinuation ( · All participants were known SAD patients who had been successfully treated with conventional light therapy in previous winters
It is very uncertain whether infrared light therapy changes overall discontinuation ( compared with no light therapy (very low certainty).
1 finding from 1 review
Overall discontinuation ( · All participants were known SAD patients who had been successfully treated with conventional light therapy in previous winters
It is very uncertain whether light therapy changes overall discontinuation ( compared with no light therapy (very low certainty).
1 finding from 1 review
Overall discontinuation ( · adults with a history of SAD but without depressive symptoms when treatment started
It is very uncertain whether mindfulness‐based cognitive therapy (MBCT) changes overall discontinuation rate compared with treatment (very low certainty).
1 finding from 1 review
Linezolid discontinuationl · drug‐resistant pulmonary tuberculosis
1 finding from 1 review